Mitochondrial dysfunction-related genes in hepatocellular carcinoma

Frontiers in Bioscience

Volumn 18, Issue 3, 2013, Pages 1141-1149

  Wang, Weilin ^a,b,c   Sun, Qiang ^a,b,c   Wu, Zehui ^a,b,c   Zhou, Dongkai ^a,b,c   Wei, Jianfeng ^a,b,c   Xie, Haiyang ^a,b,c   Zhou, Lin ^a,b,c   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c KEY LABORATORY OF ORGAN TRANSPLANTATION   (China)

Author keywords

Gene; Hepatocellular carcinoma; Mitochondrial dysfunction; Review

Indexed keywords

EID: 84880537752     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4169     Document Type: Article

References (78)

1. Gomaa AI, Khan SA, Toledano MB, Waked I and Taylor Robinson SD: hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 14, 4300-4308 (2008).
2. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr: International trends and patterns of primary liver cancer. Int J Cancer 94, 290-296 (2001). (Pubitemid 32911426)
3. Bosch FX, Ribes J, Díaz M, Cléries R: Primary Liver Cancer: Worldwide Incidence and Trends. Gastroenterology 127, S5-S16 (2004). (Pubitemid 39423365)
4. Larson AM: The Epidemiology of Hepatocellular Carcinoma in HCV. Curr Hepat Reps 4, 145-152 (2005).
5. Caldwell S and Park SH: The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 44, 96-101 (2009).
6. Maki A, Kono H, Gupta M, Asakawa M, Suzuki T, Matsuda M, Fujii H and Rusyn I: Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Anal Surg Oncol 14, 1182-1190 (2007).
7. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M and Hirohashi S: Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106, 1618-1624 (1994). (Pubitemid 24163135)
8. Minagawa M, Makuuchi M, Takayama T and Kokudo N: Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238, 703-710 (2003). (Pubitemid 38182262)
9. Hanahan D and Weinberg R A: Hallmarks of cancer: The next generation. Cell 144(5), 646-674 (2011).
10. Fulda S and Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25(34), 4798-4811(2006). (Pubitemid 44187627)
11. Freisinger P, Fütterer N, Lankes E: Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch Neurol 63(8), 1129-1134 (2006). (Pubitemid 44232319)
12. Yin PH, Wu CC, Lin JC, Chi CW, Wei YH, Lee HC: Somatic mutations of mitochondrial genome in hepatocellular carcinoma. Mitochondrion 10(2), 174-182 (2010).
13. Kim DG: Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma. Methods Mol Biol 317, 141- 155 (2006).
14. Oh S, Kim N, Lee Y: Identification of differentially expressed genes in human hepatoblastoma cell line (HepG2) and HBV-X transfected hepatoblastoma cell line (HepG2-4x). Mol Cells 8(2), 212-218 (1998). (Pubitemid 128479424)
15. Kim CM, Koike K, Saito I, Miyamura T, Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351, 317-320 (1991). (Pubitemid 21896589)
16. Zhu H, Wang Y, Chen J, Cheng G, Xue J: Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis. Exp Mol Pathol 76, 44-50 (2004). (Pubitemid 38096318)
17. Miao J, Chen GG, Chun SY, Lai PP: Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett 236(1), 115-124 (2006).
18. Saito I, Miyamura T, Ohbayashi A: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547-6549 (1990).
19. Simonetti R G, Camma C, Fiorello F: Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 116, 97-102 (1992).
20. Moriya K, Nakagawa K, Santa T: Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61(11), 4365-4370 (2001). (Pubitemid 32685760)
21. Otera H, Mihara K: Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem 149, 241-251 (2011).
22. Zhu Q, Xu YM, Wang LF: Heat shock protein 70 silencing enhances apoptosis inducing factor-mediated cell death in hepatocellular carcinoma HepG2 cells. Cancer Biol Ther 8(9), 792-798 (2009).
23. Yu GR, Qin WW, Li JP: HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells. Biosci Rep 32(3), 271-279 (2012).
24. Fu L, Dong SS, Xie YW: Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma. Hepatology 51(5), 1624-1634 (2010).
25. Tang N, Jin J, Deng Y, Ke RH, Shen QJ, Fan SH, Qin WX: LASS2 interacts with V-ATPase and inhibits cell growth of hepatocellular carcinoma. Sheng Li Xue Bao 62(3), 196-202 (2010).
26. Fausto N, Laird AD and Webber EM: Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 9(15), 1527- 1536(1995).
27. Oberhammer FA, Pavelka M, Sharma S: Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A 89, 5408-5412 (1992).
28. Gressner AM, Lahme B, Mannherz H-G and Polzar B: TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 26, 1079-1092 (1997). (Pubitemid 27242598)
29. Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M: Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene 18(34), 4879-4883 (1999). (Pubitemid 29423571)
30. Zhang H, Ozaki I, Mizuta T: Involvement of programmed cell death 4 in transforming growth factorbeta1- induced apoptosis in human hepatocellular carcinoma. Oncogene 25(45), 6101-6112 (2006). (Pubitemid 44562408)
31. Halaby MJ and Yang DQ: p53 translational control: A new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 395, 1-7 (2007).
32. Coutts AS and La Thangue N: The p53 response during DNA damage: impact of transcriptional cofactors. Biochem Soc Symp 73, 181-189 (2006). (Pubitemid 44884522)
33. Zinkel S, Gross A and Yang E: Bcl-2 family in DNA damage and cell cycle control. Cell Death Differ 13, 1351- 1359 (2006). (Pubitemid 44057470)
34. Moll UM, Wolff S, Speidel D and Deppert W: Transcriptionindependent pro-apoptotic functions of p53. Curr Opin Cell Biol 17, 631-636 (2005).
35. Cory S, Huang DC, Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22, 8590-607 (2003). (Pubitemid 38028528)
36. Ferri KF, Kroemer G: Organelle-specific initiation of cell death pathways. Nat Cell Biol 3, E255-63 (2001).
37. Jeong SY, Seol DW: The role of mitochondria in apoptosis. BMB Rep 41, 11-22 (2008).
38. Shin DY, Kim GY, Kim ND: Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells. Oncol Rep 19, 517-526 (2008). (Pubitemid 351176115)
39. Schilling T, Kairat A, Melino G: Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma. Biochem Biophys Res Commun 394, 817-823 (2010).
40. Müller M, Schilling T, Sayan AE: TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ 12, 1564-1577 (2005). (Pubitemid 41679162)
41. Mundt HM, Stremmel W, Melino G, Krammer PH, Schilling T, Müller M: Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways. Biochem Biophys Res Commun 396, 335-341 (2010).
42. Schuster A, Schilling T, De Laurenzi V: ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria. Cell Cycle 9, 2629-2639 (2010).
43. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC: Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160, 189-200 (2003). (Pubitemid 36254953)
44. Eura Y, Ishihara N, Oka T, Mihara K: Identification of a novel protein that regulates mitochondrial fusion by modulating mitofusin (Mfn) protein function. J Cell Sci 119, 4913-4925 (2006). (Pubitemid 46017804)
45. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC: Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160, 189-200 (2003). (Pubitemid 36254953)
46. Guo X, Chen KH, Guo Y, Liao H, Tang J, Xiao RP: Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res 101, 1113-1122 (2007). (Pubitemid 350146437)
47. Karbowski M, Lee YJ, Gaume B: Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol 159, 931-938 (2002). (Pubitemid 36055748)
48. Qu L, Wang WL, Wei JF, Zhou WH, Zheng SS: Clinical significance of heterozygosity loss at Mfn2 gene in hepatocellular carcinoma. Zhejiang Da Xue Xue Bao Yi Xue Ban 39, 506-510 (2010).
49. Wang W, Cheng X, Lu J: Mitofusin-2 is a novel direct target of p53. Biochem. Biophys Res Commun 400, 587- 592 (2010).
50. Wang W, Lu J, Zhu F: Pro-apoptotic and antiproliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells. Med Oncol 29, 70-76 (2012).
51. Wang W, Zhou D, Wei J: Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells. Biochem Biophys Res Commun 421, 355-360 (2012).
52. Adams JM: Ways of dying: multiple pathways to apoptosis. Genes Dev 17, 2481-2495 (2003). (Pubitemid 37271417)
53. Green DR, Evan GI: A matter of life and death. Cancer Cell 1, 19-30 (2002). (Pubitemid 41039172)
54. Yang H, Nie Y, Li Y, Wan YJ: Histone modificationmediated CYP2E1 gene expression and apoptosis of HepG2 cells. Exp Biol Med (Maywood) 235, 32-39 (2010).
55. Glushakova LG, Lisankie MJ, Eruslanov EB: AAV3- mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells. Mol Genet Metab 98, 289-299 (2009).
56. Burchard J, Zhang C, Liu AM: microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 6, 402 (2010).
57. Palmieri F: The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch 447, 689-709 (2004). (Pubitemid 38241455)
58. Kunji ER: The role and structure of mitochondrial carriers. FEBS Lett 564, 239-44 (2004). (Pubitemid 38520927)
59. del Arco A, Satrústegui J: New mitochondrial carriers: an overview. Cell Mol Life Sci 62, 2204-27 (2005). (Pubitemid 41500539)
60. Szklarczyk R, Huynen MA: Expansion of the human mitochondrial proteome by intra- and inter-compartmental protein duplication. Genome Biol 10, R135 (2009).
61. Traba J, Satrústegui J, del Arco A: Characterization of SCaMC-3-like/slc25a41, a novel calcium-independent mitochondrial ATP-Mg/Pi carrier. Biochem J 418, 125-33 (2009).
62. Hughes J, Criscuolo F: Evolutionary history of the UCP gene family: gene duplication and selection. BMC Evol Biol 8, 306 (2008).
63. Palmieri F, Pierri CL, De Grassi A, Nunes-Nesi A, Fernie AR: Evolution, structure and function of mitochondrial carriers: A review with new insights. Plant J 66, 161-81 (2011).
64. Ricketts SL, Carter JC, Coleman WB: Identification of three 11p11.2 candidate liver tumor suppressors through analysis of known human genes. Mol Carcinog 36, 90-99 (2003). (Pubitemid 36183901)
65. Lin JT, Hsiao KJ, Chen CY: High resolution melting analysis for the detection of SLC25A13 gene mutations in Taiwan. Clin Chim Acta 412, 460-465 (2011).
66. Wang J, Wang XF, Zhang LG: Involvement of the mitochondrial pathway in p53-independent apoptosis induced by p28GANK knockdown in Hep3B cells. Cytogenet Genome Res 125, 87-97 (2009).
67. Seitz SJ, Schleithoff ES, Koch A: Chemotherapyinduced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway. Int J Cancer 126, 2049-2066 (2010).
68. Waris G, Huh KW, Siddiqui A: Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 21, 7721-7730 (2001). (Pubitemid 32988782)
69. Darnell J E. Jr STATs and gene regulation. Science 277, 630-635 (1997).
70. Zhong Z, Wen W, Darnell JE Jr Stat-3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95-98 (1994). (Pubitemid 24144493)
71. Zhang Y, Zhang JW, Lv GY, Xie SL, Wang GY: Effects of STAT3 gene silencing and rapamycin on apoptosis in hepatocarcinoma cells. Int J Med Sci 9, 216-224 (2012).
72. Cheng AC, Tsai ML, Liu CM: Garcinol inhibits cell growth in hepatocellular carcinoma Hep3B cells through induction of ROS-dependent apoptosis. Food Funct 1, 301-307 (2010).
73. Wen J, You KR, Lee SY, Song CH, Kim DG: Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide. J Biol Chem 277, 38954- 38964 (2002). (Pubitemid 35154761)
74. Xu HN, Huang WD, Cai Y: HCCS1-armed, quadrupleregulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy. Mol Cancer 10, 133 (2011).
75. He C, Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43, 67- 93 (2009).
76. Gong K, Chen C, Zhan Y, Chen Y, Huang Z, Li W: Autophagy-related Gene 7 (ATG7) and Reactive Oxygen Species/Extracellular Signal-regulated Kinase Regulate Tetrandrine-induced Autophagy in Human Hepatocellular Carcinoma. J Biol Chem 287, 35576-88 (2012).
77. Chang Y, Yan W, He X: miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 143, 177-87.e8 (2012).
78. Wang N, Feng Y, Zhu M: Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: The cellular mechanism. J Cell Biochem 111, 1426-36 (2010).